David R. Walt, Director at Cerulean Pharma Inc. (CERU), bought 8,850 shares at $2.03 ($18K) on 2016-02-11, disclosed to the SEC on 2016-02-12.
Scheduled purchase ($18k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.08 | 4,500 | $9K | 51.5% |
| 2 | $2.03 | 4,350 | $9K | 48.5% |
| Total | $2.06 avg | 8,850 | $18K | 100% |
| Filing → |
| QTRX | BUY | 2024-09-17 | $625K | — | Filing → |
| QTRX | BUY | 2022-08-10 | $2.6M | — | Filing → |
| QTRX | BUY | 2020-03-17 | $1.8M | — | Filing → |